| http://www.w3.org/ns/prov#value | - Percentage of Participants With Adverse Events [ Time Frame: Baseline to the end of study (up to 40 weeks) ] [ Designated as safety issue: Yes ]The percentage of participants with serious adverse events and other adverse events is summarized by MedDRA preferred terms and organ classes in the Reported Adverse Events section below.
|
